ABCC4, ITPA, NUDT15, TPMT and their interaction as genetic predictors of 6-mercaptopurine intolerance in chinese patients with acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

ABCC4, ITPA, NUDT15, TPMT and their interaction as genetic predictors of 6-mercaptopurine intolerance in chinese patients with acute lymphoblastic leukemia

Published:2021-10-19 Issue: Volume: Page:1-13
ISSN:0888-0018
Container-title:Pediatric Hematology and Oncology
language:en
Short-container-title:Pediatric Hematology and Oncology

Author:

Fan Paroni O. L.¹,Leung Kam-Tong¹²,Chan Kathy Y. Y.¹,Leung Alex W. K.¹³,Lam Grace K. S.³,Chow Terry T. W.³,Cheng Frankie W. T.³,Yuen Liz Y. P.⁴,Moriyama Takaya⁵,Yang Jun J.⁵,Li Chi-Kong¹²³^ORCID

Affiliation:

1. Department of Paediatrics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China

2. Hong Kong Hub of Paediatric Excellence, The Chinese University of Hong Kong, Hong Kong SAR, China

3. Department of Paediatrics & Adolescent Medicine, The Hong Kong Children’s Hospital, Hong Kong SAR, China

4. Department of Pathology, The Hong Kong Children’s Hospital, Hong Kong SAR, China

5. Department of Pharmaceutical Sciences, St Jude Children’s Research Hospital, Memphis, Tennessee, USA

Funder

Private Donation ‘Mr. and Mrs. Wu Fund’

Publisher

Informa UK Limited

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

https://www.tandfonline.com/doi/pdf/10.1080/08880018.2021.1973628

Reference29 articles.

1. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli l-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial

2. Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial

3. Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000

4. Treatment of Acute Lymphoblastic Leukemia

5. NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innovating Thiopurine Therapeutic Drug Monitoring: A Systematic Review and Meta-Analysis on DNA-Thioguanine Nucleotides (DNA-TG) as an Inclusive Biomarker in Thiopurine Therapy;Clinical Pharmacokinetics;2024-07-20

2. Phytotherapeutics in Cancer: From Potential Drug Candidates to Clinical Translation;Current Topics in Medicinal Chemistry;2024-05

3. Association between genetic variants of membrane transporters and the risk of high-grade hematologic adverse events in a cohort of Mexican children with B-cell acute lymphoblastic leukemia;Frontiers in Oncology;2024-01-10

4. Association of <i>NUDT15</i> gene polymorphism with adverse reaction, treatment efficacy, and dose of 6-mercaptopurine in patients with acute lymphoblastic leukemia: a systematic review and meta-analysis;Haematologica;2023-10-05

5. Incidence and determinants of hematotoxicity in acute lymphoblastic leukemia children who received 6-mercaptopurine based maintenance therapy in Addis Ababa, Ethiopia;PLOS ONE;2023-06-02